Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
Wenzl FA, Bruno F, Kraler S, Klingenberg R, Akhmedov A, Ministrini S, Santos K, Godly K, Godly J, Niederseer D, Manka R, Bergmann A, Camici GG, von Eckardstein A, Stähli B, Muller O, Roffi M, Räber L, Lüscher TF. Wenzl FA, et al. Among authors: santos k. Eur Heart J. 2023 Oct 12;44(38):3859-3871. doi: 10.1093/eurheartj/ehad545. Eur Heart J. 2023. PMID: 37632743
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial.
van Lier D, Picod A, Marx G, Laterre PF, Hartmann O, Knothe C, Azibani F, Struck J, Santos K, Zimmerman J, Bergmann A, Mebazaa A, Pickkers P. van Lier D, et al. Among authors: santos k. Front Med (Lausanne). 2022 Dec 1;9:1058235. doi: 10.3389/fmed.2022.1058235. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530868 Free PMC article.
Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study.
van Lier D, Deniau B, Santos K, Hartmann O, Dudoignon E, Depret F, Plaud B, Laterre PF, Mebazaa A, Pickkers P. van Lier D, et al. Among authors: santos k. ERJ Open Res. 2023 Jan 9;9(1):00342-2022. doi: 10.1183/23120541.00342-2022. eCollection 2023 Jan. ERJ Open Res. 2023. PMID: 36628268 Free PMC article.
High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial.
Picod A, Nordin H, Jarczak D, Zeller T, Oddos C, Santos K, Hartmann O, Herpain A, Mebazaa A, Kluge S, Azibani F, Karakas M. Picod A, et al. Among authors: santos k. J Card Fail. 2025 Jan;31(1):29-36. doi: 10.1016/j.cardfail.2024.03.014. Epub 2024 Apr 30. J Card Fail. 2025. PMID: 38697465 Free article. Clinical Trial.
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury.
Garcia B, Ter Schiphorst B, Santos K, Su F, Dewachter L, Vasques-Nóvoa F, Rocha-Oliveira E, Roncon-Albuquerque R Jr, Uba T, Hartmann O, Picod A, Azibani F, Callebert J, Goldman S, Annoni F, Favory R, Vincent JL, Creteur J, Taccone FS, Mebazaa A, Herpain A. Garcia B, et al. Among authors: santos k. Intensive Care Med Exp. 2024 Jun 7;12(1):53. doi: 10.1186/s40635-024-00638-3. Intensive Care Med Exp. 2024. PMID: 38849640 Free PMC article.
Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severity.
Cabrera-Alarcon JL, Cruz R, Rosa-Moreno M, Latorre-Pellicer A, de Almeida SD; Scourge Cohort Group; Riancho JA, Rojas-Martinez A, Flores C, Lapunzina P, Sánchez-Cabo F, Carracedo Á, Enriquez JA. Cabrera-Alarcon JL, et al. Commun Biol. 2025 Jan 9;8(1):33. doi: 10.1038/s42003-024-07314-y. Commun Biol. 2025. PMID: 39789223 Free PMC article.
1,160 results